Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
AORT Transcript
Artivion, Inc. (AORT) Q1 2026 Earnings Call Transcript
Unknown5-10
The earnings call summary presents a mixed picture: positive trends in gross margins, reduced interest expenses, and improved cash flow are offset by challenges such as international stent graft sales and AMDS starter set barriers. The Q&A highlights cautious guidance due to geopolitical and supply chain issues. While the company is optimistic about future product launches, current uncertainties and management's reluctance to provide detailed guidance suggest a neutral market reaction. Given the small market cap, any positive or negative developments could lead to more pronounced stock movements.
Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript
Positive2-12
The earnings call reveals strong financial performance, optimistic guidance, and strategic product development, especially with AMDS and NEXUS. The Q&A section highlights management's confidence in market opportunities and competitive positioning. Despite some unclear responses, the overall tone is positive. With a market cap of ~$1 billion, the stock is likely to see a positive reaction, in the 2% to 8% range, over the next two weeks.
Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript
Positive11-6
The company shows strong growth across product lines, increased revenue guidance, and improved EBITDA margins. The Q&A reveals excitement around On-X's unique clinical data and AMDS's strong demand. Although management avoided specific 2026 guidance, the positive outlook for product launches and market expansions supports a positive sentiment. With a market cap of approximately $1 billion, the stock is likely to react positively, with a predicted movement of 2% to 8%.
Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Neutral9-10
AORT Slides
AORT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
